Regulatory Policies, Procedures and Prerequisites for Clinical Research

  • Statistical issues in drug developmenrt
  • Regulatory initiatives to promote the use of pharmacogenomics in drug development
  • Investigation of new drugs
  • Relevance of bioequivalence in approving generic copies of drug products
  • Electronic regulatory submission and review
  • Drug application regulatory compliance
  • New drug quality assessment

Related Conference of Regulatory Policies, Procedures and Prerequisites for Clinical Research

Regulatory Policies, Procedures and Prerequisites for Clinical Research Conference Speakers